Search This Blog

Thursday, February 2, 2023

Quest Diagnostics Guides FY23 Adj. EPS In Line With Estimates

 While reporting financial results for the fourth quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects earnings in a range of $7.61 and $8.21 per share and adjusted earnings in a range of $8.40 and $9.00 per share on net revenues between $8.83 billion and $9.03 billion.

On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $8.69 per share on revenues of $9.13 billion for the year. Analysts' estimates typically exclude special items.


https://www.nasdaq.com/articles/quest-diagnostics-guides-fy23-adj.-eps-in-line-with-estimates-update

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.